3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Ovarian Neoplasms
1
Neoplasm Metastasis
1
Melanoma
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
Radiosurgery
33
Radiotherapy
19
Temozolomide
16
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
7
Cyclophosphamide
7
trastuzumab deruxtecan
4
temsirolimus
4
Sunitinib
4
Specimen Handling
4
Mental Status and Dementia Tests
4
motexafin gadolinium
3
fludarabine phosphate
3
fludarabine
3
aldesleukin
3
Trastuzumab
3
Pemetrexed
3
Fluorodeoxyglucose F18
3
Erlotinib Hydrochloride
3
Dexamethasone
3
Capecitabine
3
Bevacizumab
3
pembrolizumab
2
entrectinib
2
efaproxiral
2
Vinorelbine
2
Topotecan
2
Sorafenib
2
Radiotherapy, Intensity-Modulated
2
Quality of Life
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Patient-Specific Modeling
×
CNS
×
Clear all
NCT02000739
2014-07-14
GENIUS
Dartmouth-Hitchcock Medical Center
Phase 4
Withdrawn